ReedGroup’s drug formulary aligns with its ACOEM treatment guidelines to establish effective treatment protocols for work-related injuries and illnesses. By selecting ReedGroup’s ACOEM-based formulary as a driver of the state’s approved drug list, the New York State Workers’ Compensation Board is helping lead a national movement toward implementing a drug formulary with explicit and transparent ties to evidence-based treatment guidelines.